The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 401–500 of 744
Emerging mRNA Technology for Liver Disease Therapy
Wang, J., Fang, Y., Luo, Z., Wang, J., & Zhao, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c02987 · Cited by 20
Self-citationTariq, H., Bukhari, S. Z., An, R., Dong, J., Ihsan, A., & Younis, M. R. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101440 · Cited by 18
Therapeutic Strategies and Enhanced Production of Stem Cell-Derived Exosomes for Tissue Regeneration
Kim, H., Kim, D., Kim, W., Lee, S., Gwon, Y., Park, S., & Kim, J. (2023) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2022.0118 · Cited by 17
Inhaled non-viral delivery systems for RNA therapeutics
Huang, C., Li, H., Duan, X., Zhang, P., Qi, S., Du, J., Song, X., Tong, A., & Yu, G. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.033 · Cited by 21
mRNA delivery systems 2.0: Engineering extrahepatic delivery for non-vaccine therapeutics
Dalabehera, M., Ghosh, A., Mohanty, S., Chellappan, D. K., Chaudhari, S., Ale, Y., Poonia, N., Subudhi, R. N., Khanna, M., & Lim, H. G. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102584 · Cited by 22
Microtrap Array on a Chip for Localized Electroporation and Electro-Gene Transfection
Muralidharan, A., Pesch, G. R., Hubbe, H., Rems, L., Nouri‐Goushki, M., & Boukany, P. E. (2022) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2022.108197 · Cited by 17
Function and Clinical Significance of Circular RNAs in Thyroid Cancer
Yao, X., & Zhang, Q. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.925389 · Cited by 18
Advances in mRNA nanomedicines for malignant brain tumor therapy
Deng, T., Hasan, I., Roy, S., Liu, Y., Zhang, B., & Guo, B. (2022) · Smart Materials in Medicine · doi:10.1016/j.smaim.2022.11.001 · Cited by 18
Therapeutic Applications of Extracellular Vesicles in Inflammatory Bowel Disease
Kim, S. H., Keum, B., Kwak, S., Byun, J., Shin, J., & Kim, T. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020745 · Cited by 17
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges
Liu, T., Sun, L., Ji, Y., & Zhu, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189101 · Cited by 17
Self-citationDelivery of mRNA Using Biomimetic Vectors: Progress and Challenges
Yin, M., Sun, H., Li, Y., Zhang, J., Wang, J., Liang, Y., & Zhang, K. (2024) · Small · doi:10.1002/smll.202402715 · Cited by 18
Engineered Exosomes Containing Cathelicidin/LL‐37 Exhibit Multiple Biological Functions
Su, Y., Sharma, N. S., John, J. V., Ganguli‐Indra, G., Indra, A. K., Gombart, A. F., & Xie, J. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202200849 · Cited by 20
Self-citationZhang, H., Yao, J., Jiang, Q., Shi, Y.-R., Ge, W., & Xu, X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070935 · Cited by 16
From conventional to cutting-edge: Exosomes revolutionizing nano-drug delivery systems
Fu, H., Chen, Y., Fu, Q., Lv, Q., Zhang, J., Yang, Y., Tan, P., Wang, X., Yang, Y., & Wu, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.156685 · Cited by 18
Self-citationJin, Y., Zhang, Y., Song, M., Zhou, J., Zhang, H., & Ding, Y. (2026) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100344 · Cited by 17
Advanced Immunotherapy Approaches for Glioblastoma
Ma, Y., Yang, Z., Huntoon, K. M., Jiang, W., & Kim, B. Y. S. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100046 · Cited by 16
Self-citationExosomes-mediated tumor treatment: One body plays multiple roles
Xu, N., Guo, R., Yang, X., Li, N., Yu, J., & Zhang, P. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.08.003 · Cited by 16
Pancholi, S., Tripathi, A., Bhan, A., Acharya, M. M., & Pillai, P. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02752-3 · Cited by 16
Cell-Derived Vesicles for mRNA Delivery
Li, Z., Liu, Z., Wu, J., & Li, B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122699 · Cited by 16
Nanovesicles based drug targeting to control tumor growth and metastasis
Ansari, A., Hussain, A., Wadekar, R. R., Altamimi, M. A., Malik, A., Mujtaba, M. A., Ansari, M. Y., Siddique, M. U. M., & Goyal, S. N. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100083 · Cited by 16
Lim, Y., Jung, G. N., Park, W.-T., Seo, M., & Lee, G. W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1151357 · Cited by 16
Drug delivery of extracellular vesicles: Preparation, delivery strategies and applications
Lin, S.-W., Tsai, J., & Shyong, Y. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123185 · Cited by 16
Mohamed, E., Ahmed, O. M., Zoheir, K. M. A., El‐Shahawy, A. A. G., Tamur, S., Shams, A. M., Burcher, J. T., Bishayee, A., & Abdel‐Moneim, A. (2023) · Cancers · doi:10.3390/cancers15205102 · Cited by 16
Asfiya, R., Xu, L., Paramanantham, A., Kabytaev, K., Chernatynskaya, A., McCully, G., Yang, H., & Srivastava, A. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01404 · Cited by 18
Tiwari, P., Yadav, D. K., Shukla, R. P., Bakshi, A. K., Panwar, D., Das, S., & Mishra, P. R. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110022 · Cited by 16
Liu, S., Xu, Y., Wang, X., Zhou, H., & Zhang, T. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.153914 · Cited by 16
Self-citationGe, K., Ren, Y., Hong, Z., Mao, Z., Yao, B., Ye, K., & Jia, C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401990 · Cited by 16
Application of BERT to Enable Gene Classification Based on Clinical Evidence
Su, Y., Xiang, H., Xie, H., Yu, Y., Dong, S., Yang, Z., & Zhao, N. (2020) · BioMed Research International · doi:10.1155/2020/5491963 · Cited by 17
Self-citationEngineering of Extracellular Vesicles Based on Payload Changes for Tissue Regeneration
Park, D. J., & Seo, Y. J. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00349-w · Cited by 16
Optimal delivery strategies for nanoparticle-mediated mRNA delivery
Li, X., Guo, X., Hu, M., Cai, R., & Chen, C. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02455a · Cited by 16
Ghanam, J., Lichá, K., Chetty, V. K., Pour, O. A., Reinhardt, D., Konečná, B., Hoyer, P. F., Lötvall, J. O., & Thakur, B. K. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70047 · Cited by 15
Advances in hybrid exosome-liposome nanoparticles for enhanced cancer therapy
Dou, J., Wang, J., Zhang, G., Fu, X., Zhang, Y., & Sun, F. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115317 · Cited by 15
Modern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics
Fedorova, O. V., Ovchinnikova, I. G., Rusinov, G. L., Avdeeva, V. V., Zhdanov, А. P., Zhizhin, K. Y., Kuznetsov, N. T., Zakharova, L. Y., Kuznetsova, D. A., Razuvayeva, Y. S., et al. (2025) · Russian Journal of General Chemistry · doi:10.1134/s1070363225606726 · Cited by 16
Exosomes for diabetes syndrome: ongoing applications and perspective
Zhu, M., Wu, J., & Gao, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00161f · Cited by 16
Keysberg, C., Schneider, H., & Otte, K. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28322 · Cited by 15
Engineered Exosomes as Theranostic Platforms for Cancer Treatment
Yang, X., Xie, X., Liu, S., Ma, W., Zheng, Z., Wei, H., & Yu, C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00745 · Cited by 17
Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.
Qin, B., Zhāng, Q., Chen, D., Yu, H., Luo, A.-X., Suo, L. P., Cai, Y., Cai, D., Luo, J., Huang, J., et al. (2021) · PubMed · doi:10.14670/hh-18-297 · Cited by 16
Genetically engineered cell-derived nanovesicles for cancer immunotherapy
He, S., & Zhao, Z. (2024) · Nanoscale · doi:10.1039/d3nr06565k · Cited by 15
Xu, M., Ren, M., Zhang, X., Peng, W., Liao, W., Liao, W., Xie, J., & Zhang, X. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.10.034 · Cited by 14
Self-citationSun, M., Zhang, H., Ma, Y., Wang, S., Chen, J., Cui, Y., Zhang, Y., Hu, S., Zhou, D., Zhang, P., et al. (2025) · Advanced Science · doi:10.1002/advs.202504008 · Cited by 14
Self-citationZhang, Y. C., Li, Z., Guan, H., Qiu, Z., & Zou, C. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70548 · Cited by 17
Saha, P., Datta, S., Ghosh, S., Samanta, A., Ghosh, P., & Sinha, D. (2021) · Bioengineering · doi:10.3390/bioengineering8100139 · Cited by 15
Exosomal LncRNAs and hepatocellular Carcinoma: From basic research to clinical practice
Li, L., Bi, Y., Diao, S., Li, X., Yuan, T., Xu, T., Huang, C., & Li, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115032 · Cited by 14
Effective mRNA Delivery by Condensation with Cationic Nanogels Incorporated into Liposomes
Duskunovic, N., Im, S. H., Lee, J. H., & Chung, H. J. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00089 · Cited by 14
Agborbesong, E., Bissler, J. J., & Li, X. (2023) · Genes · doi:10.3390/genes14071367 · Cited by 19
Nanotechnology of inhalable vaccines for enhancing mucosal immunity
Li, Q., Sun, Y., Gao, N., Ling, G., & Zhang, P. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01431-7 · Cited by 14
Ren, J., Jing, X., Liu, Y., Liu, J., Ning, X., Zong, M., Zhang, R., Cheng, H., Cui, J., Li, B., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02277-4 · Cited by 15
Lin, J., Li, K., Yang, Z., Cao, F., Gao, L., Ning, T., Xing, D., Zeng, H., Liu, Q., Ge, Z., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.03.006 · Cited by 14
Self-citationJia, X., Yuan, B., Wang, W., Wang, K., Ling, D., Meng, W., Hu, Y., Guo, W., Chen, Z., Du, L., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03065-4 · Cited by 14
Safarzadeh, M., Saadat, N., Abbasi-Molaei, S., & Rastegari‐Pouyani, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02283-z · Cited by 14
Pregnancy and placental development in horses: an update
Chavatte‐Palmer, P., Derisoud, E., & Robles, M. (2021) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2021.106692 · Cited by 14
Xu, Y., Cheung, C. Y. M., Liu, L., Cheung, H. P., Tam, K. Y., Ker, D. F. E., Cartmell, S. H., Mao, C., Zhang, Z., & Wang, D. M. (2025) · BMEMat · doi:10.1002/bmm2.70012 · Cited by 14
Ding, L., Zhang, T., Pan, Y., Liu, J., Ma, T., Zhou, H., Zhu, Q., Tai, Z., & Chen, Z. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102298 · Cited by 14
Bao, X., Chen, L., Yu, H. J., Xie, Y., Luo, L., Luo, L., Wang, H., Chen, R., Cheng, Y., Sun, D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1677808 · Cited by 14
Xu, H., Liu, R., Zhou, H., Kong, B., Shen, K., Zhao, T., Du, X., Zhang, H., Song, H., Guo, D., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.029 · Cited by 15
Engineered multitargeting exosomes carrying miR-323a-3p for CRC therapy
Pang, Y., Chen, X., Xu, B., Zhang, Y., Liang, S., Hu, J., Liu, R., Luo, X., & Wang, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125794 · Cited by 13
Self-citationAdvances in synthetic biology-based drug delivery systems for disease treatment
Li, Y., Wang, Y., Luo, Y.-G., Yang, H., Ren, J., & Xiao, L. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109576 · Cited by 14
Self-citationRecent advances in mRNA-based therapeutics for neurodegenerative diseases and brain tumors
Yang, L., Li, S., Hou, C., Wang, Z., He, W., & Zhang, W. (2024) · Nanoscale · doi:10.1039/d4nr04394d · Cited by 15
Tandon, R., & Srivastava, N. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123472 · Cited by 19
Tang, H., Wang, J., Yu, L., Zhang, S., He, Y., Li, X., Brash, J. L., Wang, L., & Chen, H. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c22736 · Cited by 13
What’s Next after Lipid Nanoparticles? A Perspective on Enablers of Nucleic Acid Therapeutics
Das, R., Kanjilal, P., Medeiros, J., & Thayumanavan, S. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00058 · Cited by 13
Lin, J., Jia, S., Jiao, Z., Chen, J., Li, W., Cao, F., & Zhang, X. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00507-z · Cited by 13
Recent Advances in mRNA Delivery Systems for Cancer Therapy
Zhang, Z., Fan, Y., Jiang, S., Ma, Y., Yu, Y., Qing, Y., Li, Q., Liu, Y., Shen, S., & Wang, J. (2025) · Advanced Science · doi:10.1002/advs.202417571 · Cited by 17
Self-citationYang, M., Zhou, W., Han, X. L., Xu, M., Wang, Z., Shi, M., Shi, Y., & Yu, Y. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70115 · Cited by 12
Zhang, T., Liu, Z., Wei, Y., Lu, J., He, Z., Wu, Z., Liu, M., Li, K., Wang, X., Li, Z., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161653 · Cited by 14
Self-citationBioengineering exosomes for treatment of organ ischemia-reperfusion injury
Toghiani, R., Abolmaali, S. S., Najafi, H., & Tamaddon, A. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120654 · Cited by 12
“All-in-One” Exosome Engineering Strategy for Effective Therapy of Familial Hypercholesterolemia
Mei, R., Wan, Z., Li, Z., Wei, M., Qin, W., Yuan, L., Liu, L., & Yang, G. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c15785 · Cited by 13
Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy
Liang, C., Zhang, Y., Wang, S., Jiao, W., Guo, J., Zhang, N., & Liu, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00230j · Cited by 14
The Importance of Small Extracellular Vesicles in the Cerebral Metastatic Process
Tămaș, F., Bălașa, R., Manu, D. R., Gyorki, G., Chinezu, R., Tămaș, C., & Bălașa, A. F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031449 · Cited by 12
Shahlaei, M., Afkhami, H., Ahmadieh-Yazdi, A., Mirmazloumi, S. H., Sahraei, S. S., Akbari, M., Yang, P., Manoochehri, H., Tanzadehpanah, H., Mahaki, H., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118548 · Cited by 11
The mRNA-Based Innovative Strategy: Progress and Challenges
Zhou, H., Wei, D., Chen, Z., Chen, H., Dong, C., Cai, W., Wang, J., Liu, X., Li, Y., Yang, Y., et al. (2026) · Nano-Micro Letters · doi:10.1007/s40820-025-01906-x · Cited by 17
Harnessing cGAS‐STING Pathway for Cancer Immunotherapy: From Bench to Clinic
Lee, D., Huntoon, K. M., Kang, M., Lü, Y., Gallup, T. D., Jiang, W., & Kim, B. Y. S. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200040 · Cited by 10
Self-citationNanoporous electroporation needle for localized intracellular delivery in deep tissues
Lee, G. W., Kim, B., Lee, T. W., Yim, S., Chandrasekharan, A., Kim, H., Choi, S., & Yang, S. Y. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10418 · Cited by 12
Self-citationRecent engineering advances of EVs for compounds, nucleic acids, and TCM delivery
Di, Y., Wang, W., Wang, Y., & Wang, J. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106584 · Cited by 12
Self-citationThe Role of Extracellular Vesicles in the Treatment of Prostate Cancer
Hu, C., Chen, Q., Wu, T., Du, X., Dong, Y., Peng, Z., Xue, W., Sunkara, V., Cho, Y., & Dong, L. (2024) · Small · doi:10.1002/smll.202311071 · Cited by 11
Pharmaceutical strategies for optimized mRNA expression
Shi, Y., Mao, J., Wang, S., Ma, S., Luo, L., & You, J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122853 · Cited by 11
Real‐time monitoring of small extracellular vesicles (sEVs) by in vivo flow cytometry
Zhang, F., Lu, X., Zhu, X., Yu, Z., Xia, W., & Wei, X. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70003 · Cited by 11
Zhang, S., Li, J., Hu, X., Liu, H., Yu, Q., Kuang, G., Liu, L., Yu, D., Lin, Z., & Xiong, N. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01262 · Cited by 14
Engineering Extracellular Vesicles for Cancer Therapy
Nedeva, C., & Mathivanan, S. (2021) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-67171-6_14 · Cited by 11
Odysseos, A. D., & Nakano, T. (2021) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2021.3083725 · Cited by 11
Li, G., Sun, X., Wan, X., & Wang, D. (2020) · Dose-Response · doi:10.1177/1559325820917836 · Cited by 11
Chemical strategies for brain delivery of genomic therapy
Li, H., Yu, C., Markovic, T., Nestler, E. J., & Dong, Y. (2025) · Nature Reviews Chemistry · doi:10.1038/s41570-025-00770-y · Cited by 16
Quantifying nanoparticle delivery: challenges, tools, and advances
Corral, M. Y. M., Alvarez, D. E., & Poon, W. (2023) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2023.103042 · Cited by 12
Biomimetic Cell Membrane Vehicles: Navigating the BloodBrain Barrier for Enhanced CNS Drug Delivery
Alalwani, A. K., Ahad, S., & Dhaher, H. (2023) · Trends in Pharmaceutical Biotechnology · doi:10.57238/tpb.2023.144292.1004 · Cited by 10
Beyond Traditional Medicine: EVs-Loaded Hydrogels as a Game Changer in Disease Therapeutics
Du, S., Zhou, X., & Zheng, B. (2024) · Gels · doi:10.3390/gels10030162 · Cited by 10
Zhang, W., Luo, Y., Tao, J., Liu, G., Li, B., Teng, Y., Xu, J., Feng, L., & You, Z. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160264 · Cited by 10
Ahmed, T., & Alam, K. T. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03065-z · Cited by 10
Safaei, M., Rajabi, S.-S., Tirgar, M., Namdar, N., Dalfardi, M., Mohammadifar, F., Goodarzi, A., Farmani, A. R., Ramezani, V., & Abpeikar, Z. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.03.005 · Cited by 10
Yang, W., Wang, X., Zheng, D.-W., Feng, J., Kong, W., Li, Y., Ma, G., Wei, W., & Tao, Y. K. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102052 · Cited by 11
Self-citationLiu, W., Huang, H., Shu, F., Liu, Y., Lin, J., Yang, L., Zhang, W., Jiang, L., Liu, T., Xie, C., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.013 · Cited by 11
Self-citationLi, Q., Gao, H., Ma, X., Wang, Z., Zhao, L., & Xiao, W. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5570 · Cited by 10
Wang, Y., Liu, X., Hu, G., Hu, C., Gao, Y., Huo, M., Zhu, H., Liu, M., & Xu, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.719785 · Cited by 10
Self-citationCheng, L., Salmen, S. H., Alahmadi, T. A., Veeraraghavan, V. P., Surapaneni, K. M., Nandakumar, N., & Subramanian, S. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.02.012 · Cited by 10
Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis
Zhu, Z., Zhou, Y., Li, H., Xu, W., Wang, T., Liu, J., & Jiang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1270104 · Cited by 11
Chen, J., Hu, S., Li, J., Xing, J., Yang, Z., & Teng, L. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00391 · Cited by 9
Self-citationLin, S.-W., Yu, C., Tsai, J., & Shyong, Y. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101244 · Cited by 9
Shi, J., Zhao, G., Wang, S., Wei, Y., Wu, J., Huang, G., Chen, J., & Jun, X. (2025) · Biotechnology Journal · doi:10.1002/biot.202400611 · Cited by 12
Self-citationWang, J., & Kong, Z. (2025) · Plant Biotechnology Journal · doi:10.1111/pbi.70074 · Cited by 11
Extracellular vesicle-based targeted RNA therapies against cancer
Wang, Z., Xing, H., Huang, Y., & Lu, M. (2025) · Extracellular Vesicle · doi:10.1016/j.vesic.2025.100083 · Cited by 10
Do, A. D., Chu, S.-S., Giang, L. H., Huang, P., Lin, Y., Chang, C., Wong, T., Sung, S., & Hsieh, C. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03554-0 · Cited by 11
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
